DEVELOPMENT OF HEMORRHAGIC VASCULITIS AGAINST THE BACKGROUND OF HEPATITIS B IN THE SCAR PERIOD OF MYOCARDIAL INFARCTION: A CLINICAL CASE STUDY
Keywords:
hemorrhagic vasculitis, petechial rash, joint syndrome, abdominal pain, viral hepatitis V, myocardial infarction, chronic heart failure, kidney damage, glucocorticoidsAbstract
In the practice of any doctor, a patient may develop hemorrhagic rashes on the lower extremities, bleeding from the mucous membranes, damage to the joints, and abdominal pain after suffering from an upper respiratory tract infection, tonsillitis, or flu. . The cause of abdominal pain, flatulence, stool disorders, nausea and vomiting is sometimes mixed with blood and bleeding into the intestinal wall. These symptoms are characteristic of hemorrhagic vasculitis (HV). The presence of serious comorbid pathology of this disease in the elderly does not always allow to make the correct diagnosis at the beginning of the disease. In the described clinical observation, the combination of GV and viral hepatitis V, as well as the onset of vasculitis during the scarring of a small focal myocardial infarction, lead to difficulties in differential diagnosis. There was no fever and no obvious abdominal syndrome, but arthralgia, a characteristic rash, and marked edema of the lower extremities were observed. Clinical manifestations of hepatitis V are obtained for signs of decompensation of chronic heart failure. In this regard, therapy was ineffective, and kidney damage developed depending on the type of glomerulonephritis. Correct diagnosis made it possible to start pathogenetic therapy with glucocorticoids and obtain positive dynamics of clinical manifestations.
References
Grechishkina N.V. Gemorragicheskiy vaskulit. Osnovi diagnostiki i differensialnoy diagnostiki. Spravochnik vracha obshey praktiki. 2018;2:25–32. [Grechishkina N.V. Hemorrhagic vasculitis. Basics of diagnosis and differential diagnosis. Handbook for the General practitioner. 2018;2:25–32 (in Russ.)].
Makashova V.V., Omarova X.G. Terapiya to'xtatilgandan keyin surunkali gepatit B ning qayta faollashishi. RMJ . 2019;10:50–52. [ Makashova VV, Omarova X.G Davolanish to'xtatilgandan keyin surunkali gepatit B qayta faollashishi. R.M.J. 2019; 10:50 –52 (rus tilida)].
Mamatkulova F.Kh. Shomurodov K.E.,Temirov N. N. Significance. Of Helicobacter Pylori In Iron Deficiency. International Journal for Research in Applied.Science & Engineering Technology (IJRASET)ISSN: 2321-9653; Volume.9 Issue XII Dec.2021.https://doi.org/10.22. 214/ijraset.2021.39443. 1103-1106
Maxmonov L.S., Mamatqulova F.X.,Holiqulov B.Y.Gemorragik diatezlar bilan kasallangan ayollarda tuxumdon apopleksiyasi asoratini davolash tamoyillari. “SCIENCE AND EDUCATION” VOLUME 3,ISSUE12.2022/ 237-242.
L.S.Makhmonov., F. Kh. Mamatkulova., M. B. Berdiyarova., K.E. Shomurodov.THE MAIN CAUSES OF ANEMIA IN IRON AND VITAMIN B 12 DEFICIENCY ASSOCIATED WITH HELICOBACTER PYLORI
Makhmonov L.S., Sh. Koraboev S.K., Gapparova N..Sh, Mamatkulova F. Kh. Early diagnosis and treatment of funicular myelosis in v12 deficiency anemia. Asian Journal of Multidimensional Research Year : 2022, Volume : 11, Issue : 5.First page : ( 369) Last page : ( 373)Online ISSN : 2278-4853.
Mamatkulova F. X. Mamatova N. T. Ruziboeva.O. N. Prevention Of Anemia In Patients With Tuberculosis. The American Journal of Medical Sciences and Pharmaceutical Research, 2(11), 62–65. L. S. Makhmonov., F. Kh. Mamatkulova., M. B. Berdiyarova., K.E. Shomurodov.THE MAIN CAUSES OF ANEMIA IN IRON AND VITAMIN B 12 DEFICIENCY ASSOCIATED WITH HELICOBACTER PYLORI
Makhmonov L. S., Mamatkulova F. Kh., Kholturaeva D. F., Muyiddinov Z. Z.IMPORTANCE OF DETECTION OF HEPSIDINE AND INTERLEUKINS IN IRON DEFICIENCY ANEMIA. Asian Journal of Multidimensional Research ISSN: 2278-4853 Vol. 11, Issue 4, April 2022
MF Khaydarovna, AH Isrofilovich, AK Makhmatovich Essential Thrombocythemia-Principal Analysis in Children and Adolescents. Journal of Intellectual Property and Human Rights 2 (10), 23-29
Yefremova O.A., Pridatchina L.S., Rastorguyeva G.A. i dr. Effektivnost primeneniya svejezamorojennoy plazmi pri lechenii gemorragicheskogo vaskulita. Nauchniye vedomosti Belgorodskogo gos. un-ta. Seriya: Meditsina. Farmatsiya. 2011;99(4):209–213. [Efremova O.A., Pridachin L.S., Rastorguev G.A. еt al. The efficacy of fresh frozen plasma in the treatment of hemorrhagic vasculite. Scientific statements of Belgorod state University. Series: Medicine. Pharmacy. 2011;99(4):209–213 (in Russ.)].
Abdiev Kattabek Makhmatovich, Mamatkulova Feruza Khaydarovna. Structure of comorbidity in idiopathic thrombocytopenic purple SKM ACADEMICIA: An International Multidisciplinary Research Journal 22 (12), 56-60
U.D DADAJONOV, KM ABDIEV, FX MAMATKULOVA. Innovative methods of treatment of immune thrombocytopenic purpura in young people Society and innovations, 52-56 Society and innovations, 52-56
Mamatkulova F. X., Usmonqulov J. Sh. O‘. Vitamin V12 kamqonligi va uni davolash //Science and Education. – 2023. – T. 4. – №. 2. – S. 252-259.
Makhmonov Lutfullo Saydullayevich, Amerova Dilafruz Abdikhalimovna, Kholmatov Baxtiyor Urazovich,Rakhmatov Khusniddin Tulkinovich. Innovative Treatment Methods for Brights Anemia Developed in Chronic Renal Failure International Journal for Research in Applied Science & Engineering Technology (IJRASET)ISSN: 2321-9653; IC Value: 45.98; SJ Impact Factor: 7.538. Volume 12 Issue IV Apr 2024. 620-622
Rossiyskiye klinicheskiye rekomendatsii. Revmatologiya. Pod red. Nasonova YE.L. M.: GEOTAR-Media; 2017. [Russian clinical guidelines. Rheumatology. Nasonov E.L. ed. M.: GEOTAR-Media; 2017 (in Russ.)].
Djakipbayev O.A., Raimjanov A.R. Immunologicheskiye pokazateli u bolnix gemorragicheskim vaskulitom v protsesse kombinirovannogo lecheniya. Sovremenniye tendensii razvitiya nauki i texnologiy. 2016;1–3:32–36. [Jakypbaev O.A., Raimzhanov A.R. Immunological parameters in patients with hemorrhagic vasculitis in the process of combined treatment. Modern trends in the development of science and technology. 2016;1–3:32–36 (in Russ.)].
Hong-Ya Xin, De-Jian Jiang, Su-Jie Jia et al. Regulalation by DDAN/ADMA pathway of lipopolysaccaride-induced tissue factor expression in endothelial celss. J. of Thrombosis and Haemostasis. 2007;95(5):830–838.
Jennette J., Falk R., Bacon P. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthr Rheum. 2013;65(1):1–11.
Шилкина Н.П. Системные васкулиты: некоторые дискуссионные аспекты проблемы. Терапевтический архив. 2015;87(5):100–105. [Shilkina N.P. Systemic vasculitides: Some debatable aspects of the problem. Therapeutic archive. 2015;87(5):100–105 (in Russ.)].8. Antipova V.N., Shlykova M.A., Solodovnikova L.V., Smitienko I.O. Tizimli vaskulyit : amaliyotdan kuzatishlar. Zamonaviy revmatologiya. 2015;9(3):26–29. [ Antipova VN, Shlykova MA, Solodovnikova LV, Smitienko IO Tizimli vaskulitlar : Klinik holatlar . Zamonaviy Revmatologiya J. 2015;9(3):26–29 ( in Russ .)].
Dunaeva N.V., Karev V.E., Vorobyova O.A. va boshqalar surunkali gepatit C ning antiviral terapiyasi, tizimli krioglobulinemik vaskulit . Infektologiya jurnali . 2016;8(2):40–47. [ Dunaeva NV, Karev VE, Vorobyeva OA va boshqalar al . Tizimli krioglobulinemiya bilan murakkablashgan surunkali gepatit C ning antiviral terapiyasi vaskulit . J of Infektologiya . 2016;8(2):40–47 ( dyu Russ .)].
Насырова З. А. и др. Влияние дестабилизации ишемической болезни сердца на психоэмоциональное состояние пациентов //Кардиология в Беларуси. – 2024. – №. 6 Часть 16. – С. 624-639.
Насырова З. А. Роль полиморфизма локуса-819 С/Т (rs1800871) гена IL-10 при дестабилизации ишемической болезни сердца у больных с нейросенсорными расстройствами //Journal of cardiorespiratory research. – 2022. – Т. 3. – №. 3. – С. 72-76.
Насырова З. А. ЭПИДЕМИОЛОГИЯ, ЭТИОЛОГИЧЕСКАЯ ВЗАИМОСВЯЗЬ И ПРОГНОСТИЧЕСКИЕ ПОСЛЕДСТВИЯ ДЕПРЕССИИ И ТРЕВОГИ ПРИ ИШЕМИЧЕСКИХ БОЛЕЗНЯХ СЕРДЦА //Journal of cardiorespiratory research. – 2022. – Т. 3. – №. 4. – С. 21-25.
Элламонов С. Н., Насырова З. А. КЛИНИЧЕСКИЕ И ИНСТРУМЕНТАЛЬНЫЕ ОСОБЕННОСТИ ТЕЧЕНИЯ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА У БОЛЬНЫХ C КОМОРБИДНЫМИ СОСТОЯНИЯМИ //Journal of cardiorespiratory research. – 2022. – Т. 3. – №. 1. – С. 69-72.
